Holen Sie sich die Stockscreener-App
9.52
3.35%
-0.33
Handel nachbörslich:
9.50
-0.02
-0.21%
Finanzdaten der Corvus Pharmaceuticals Inc-Aktie (CRVS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
29.71%
19.30
|
14.88 | 12.22 | 10.57 | 10.26 |
| Depreciation and Amortization |
17.24%
0.034
|
0.029 | 0.021 | 0.028 | 0.029 |
| Operating Income/Loss |
29.71%
-19.30
|
-14.88 | -12.22 | -10.57 | -10.26 |
| Income/Loss From Equity Method Investments |
18.36%
-0.709
|
-0.599 | -0.707 | -0.323 | -0.389 |
| Income/Loss From Continuing Operations Before Tax |
31.75%
-17.25
|
-13.09 | -11.61 | -9.834 | -7.609 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
31.16%
-17.96
|
-13.69 | -12.32 | -10.16 | -7.998 |
| Basic Average Shares |
2.63%
92.37
|
90.00 | - | 82.84 | 77.77 |
| Diluted Average Shares |
2.63%
92.37
|
90.00 | - | 82.84 | 77.77 |
| Basic Earnings Per Share |
26.67%
-0.19
|
-0.15 | - | -0.12 | -0.10 |
| Diluted Earnings Per Share |
26.67%
-0.19
|
-0.15 | - | -0.12 | -0.10 |
2.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):